Dna Testing St Louis from your impression earlier mentioned is an element of the Dna Testing St Louis category on Typing Tutor Test articles. Down load this graphic for free in HD resolution the selection by suitable pressing around the Dna Testing St Louis image. If you tend not to locate the precise resolution you are interested in, then go for a native or higher resolution.
1 Tomi Akinyemiju. . 2018. Epigenetic Biomarkers in Cancer Epidemiology. Epigenetic Mechanisms in Cancer, 223-241. CrossRef 2 Gerard Cummins, Diana E. Yung, Ben F. Cox, Anastasios Koulaouzidis, Marc P. Y. Desmulliez, Sandy Cochran. . (2017) Luminally expressed gastrointestinal biomarkers. Expert Review of Gastroenterology & Hepatology 11:12, 1119-1134. CrossRef 3 Marcello Maida, Fabio Salvatore Macaluso, Gianluca Ianiro, Francesca Mangiola, Emanuele Sinagra, Georgina Hold, Carlo Maida, Giovanni Cammarota, Antonio Gasbarrini, Giuseppe Scarpulla.
. (2017) Screening of colorectal cancer: present and future. Expert Review of Anticancer Therapy 17:12, 1131-1146. CrossRef 4 Meta C. J. van Lanschot, Beatriz Carvalho, Veerle M. H. Coupé, Manon van Engeland, Evelien Dekker, Gerrit A. Meijer. . (2017) Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study. BMC Cancer 17:1. CrossRef 5 Lele Song, Jia Jia, Xiumei Peng, Wenhua Xiao, Yuemin Li.
. (2017) The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis. Scientific Reports 7:1. CrossRef 6 Naoki Muguruma, Koichi Okamoto, Tadahiko Nakagawa, Katsutaka Sannomiya, Shota Fujimoto, Yasuhiro Mitsui, Tetsuo Kimura, Hiroshi Miyamoto, Jun Higashijima, Mitsuo Shimada, Yoko Horino, Shinya Matsumoto, Kenjiro Hanaoka, Tetsuo Nagano, Makoto Shibutani, Tetsuji Takayama.
. (2017) Molecular imaging of aberrant crypt foci in the human colon targeting glutathione S-transferase P1-1. Scientific Reports 7:1. CrossRef 7 Lisa J. Croner, Roslyn Dillon, Athit Kao, Stefanie N. Kairs, Ryan Benz, Ib J. Christensen, Hans J. Nielsen, John E. Blume, Bruce Wilcox. . (2017) Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects.
Clinical Proteomics 14:1. CrossRef 8 Chao-Nan Qian. . (2017) At-home cancer screening: a solution for China and other developing countries with a large population and limited number of healthcare practitioners. Chinese Journal of Cancer 36:1. CrossRef 9 Reinier G.S. Meester, Chyke A. Doubeni, Ann G. Zauber, Marjolein van Ballegooijen, Douglas A. Corley, Iris Lansdorp-Vogelaar. . (2017) Impact of adenoma detection on the benefit of faecal testing vs .
colonoscopy for colorectal cancer. International Journal of Cancer 141:11, 2359-2367. CrossRef 10 Laura Moody, Hongshan He, Yuan-Xiang Pan, Hong Chen. . (2017) Methods and novel technology for microRNA quantification in colorectal cancer screening. Clinical Epigenetics 9:1. CrossRef 11 Glenn Rademakers, Nathalie Vaes, Simone Schonkeren, Alexander Koch, Keith A. Sharkey, Veerle Melotte. . (2017) The role of enteric neurons in the development and progression of colorectal cancer.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:2, 420-434. CrossRef 12 Alberto Puccini, Martin D. Berger, Madiha Naseem, Ryuma Tokunaga, Francesca Battaglin, Shu Cao, Diana L. Hanna, Michelle McSkane, Shivani Soni, Wu Zhang, Heinz-Josef Lenz. . (2017) Colorectal cancer: epigenetic alterations and their clinical implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1868:2, 439-448.
CrossRef 13 William R. Sonnenberg. . (2017) Gastrointestinal Malignancies. Primary Care: Clinics in Office Practice 44:4, 721-732. CrossRef 14 Chung-Wei Fan, Yung-Bin Kuo, Geng-Pin Lin, Si-Min Chen, Shih-Hsien Chang, Bo-An Li, Err-Cheng Chan. . (2017) Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer. Clinica Chimica Acta 475, 157-163.
CrossRef 15 Phillip Fleshner, Glenn D. Braunstein, Gayane Ovsepyan, Theresa R. Tonozzi, Anja Kammesheidt. . (2017) Tumor-associated DNA mutation detection in individuals undergoing colonoscopy. Cancer Medicine 6. CrossRef 16 Todd Z DeSantis, Manasi S Shah, Julia L Cope, Emily B Hollister. . (2017) Microbial markers in the diagnosis of colorectal cancer: the promise, reality and challenge. Future Microbiology 12:15, 1341-1344.
CrossRef 17 Yuan-Hong Xie, Qin-Yan Gao, Guo-Xiang Cai, Xiao-Ming Sun, Tian-Hui Zou, Hui-Min Chen, Si-Yi Yu, Yi-Wen Qiu, Wei-Qi Gu, Xiao-Yu Chen, Yun Cui, Danfeng Sun, Zhan-Ju Liu, San-Jun Cai, Jie Xu, Ying-Xuan Chen, Jing-Yuan Fang. . (2017) Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies. EBioMedicine 25, 32-40. CrossRef 18 Sudhir Srivastava, Barnett S.
Kramer. . (2017) Validation: a critical step in bringing biomarkers to clinical fruition. Annals of Epidemiology. CrossRef 19 B. Saroja, A. SelwinMich Priyadharson. . (2017) Adaptive pillar K-means clustering-based colon cancer detection from biopsy samples with outliers. Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization, 1-11. CrossRef 20 Sumedha V. Chablani, Noah Cohen, Drusilla White, Steven H.
Itzkowitz, Katherine DuHamel, Lina Jandorf. . (2017) Colorectal Cancer Screening Preferences among Black and Latino Primary Care Patients. Journal of Immigrant and Minority Health 19:5, 1100-1108. CrossRef 21 Felipe Soares, Karin Becker, Michel J. Anzanello. . (2017) A hierarchical classifier based on human blood plasma fluorescence for non-invasive colorectal cancer screening. Artificial Intelligence in Medicine 82, 1-10.
CrossRef 22 Eun-Ang Raiber, Robyn Hardisty, Pieter van Delft, Shankar Balasubramanian. . (2017) Mapping and elucidating the function of modified bases in DNA. Nature Reviews Chemistry 1:9, 0069. CrossRef 23 Yi Liao, Senmao Li, Chunyu Chen, Xuan He, Feng Lin, Jianping Wang, Zuli Yang, Ping Lan. . (2017) Screening for colorectal cancer in Tianhe, Guangzhou: results of combining fecal immunochemical tests and risk factors for selecting patients requiring colonoscopy.
Gastroenterology Report. CrossRef 24 N. Vaes, M. H. F. M. Lentjes, M. J. Gijbels, G. Rademakers, K. L. Daenen, W. Boesmans, K. A. D. Wouters, A. Geuzens, X. Qu, H. P. J. Steinbusch, B. P. F. Rutten, S. H. Baldwin, K. A. Sharkey, R. M. W. Hofstra, M. van Engeland, P. Vanden Berghe, V. Melotte. . (2017) NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons.
Neurogastroenterology & Motility 29:9, e13095. CrossRef 25 Andrew Coldman, William Flanagan, Claude Nadeau, Michael Wolfson, Natalie Fitzgerald, Saima Memon, Cindy Gauvreau, Anthony Miller, Craig Earle. . (2017) Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation model. Journal of Cancer Policy 13, 38-46.
CrossRef 26 C?line Audibert, Anna Perlaky, Daniel Glass. . (2017) Global perspective on colonoscopy use for colorectal cancer screening: A multi-country survey of practicing colonoscopists. Contemporary Clinical Trials Communications 7, 116-121. CrossRef 27 Christoph Holmer, Martin E. Kreis. . (2017) Darmkrebs — das Neueste in Diagnostik und Therapie. MMW - Fortschritte der Medizin 159:16, 54-62.
CrossRef 28 Lucia R. Wu, Sherry X. Chen, Yalei Wu, Abhijit A. Patel, David Yu Zhang. . (2017) Multiplexed enrichment of rare DNA variants via sequence-selective and temperature-robust amplification. Nature Biomedical Engineering 1:9, 714-723. CrossRef 29 Satimai Aniwan, Thawee Ratanachu-Ek, Supot Pongprasobchai, Julajak Limsrivilai, Ong-Ard Praisontarangkul, Pises Pisespongsa, Pisaln Mairiang, Apichat Sangchan, Jaksin Sottisuporn, Naruemon Wisedopas, Pinit Kullavanijaya, Rungsun Rerknimitr.
. (2017) Impact of Fecal Hb Levels on Advanced Neoplasia Detection and the Diagnostic Miss Rate For Colorectal Cancer Screening in High-Risk vs. Average-Risk Subjects: a Multi-Center Study. Clinical and Translational Gastroenterology 8:8, e113. CrossRef 30 M. Danta, D. A. Barber, H. P. Zhang, M. Lee-Ng, S. W. L. Baumgart, V. W. W. Tsai, Y. Husaini, M. Saxena, C. P. Marquis, W. Errington, S. Kerr, S.
N. Breit, D. A. Brown. . (2017) Macrophage inhibitory cytokine-1/growth differentiation factor-15 as a predictor of colonic neoplasia. Alimentary Pharmacology & Therapeutics 46:3, 347-354. CrossRef 31 Chung Wah Wu, Xiaoming Cao, Calise K. Berger, Patrick H. Foote, Douglas W. Mahoney, Julie A. Simonson, Bradley W. Anderson, Tracy C. Yab, William R. Taylor, Lisa A. Boardman, John B. Kisiel, David A.
Ahlquist. . (2017) Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers. Digestive Diseases and Sciences 62:8, 1985-1994. CrossRef 32 Kevin M. Rank, Aasma Shaukat. . (2017) Stool Based Testing for Colorectal Cancer: an Overview of Available Evidence. Current Gastroenterology Reports 19:8. CrossRef 33 M. C. J. van Lanschot, L. J. W. Bosch, M. de Wit, B.
Carvalho, G. A. Meijer. . (2017) Early detection: the impact of genomics. Virchows Archiv 471:2, 165-173. CrossRef 34 P.K.C. Jonker, V.M. Meyer, S. Kruijff. . (2017) Epigenetic dysregulation in adrenocortical carcinoma, a systematic review of the literature. Molecular and Cellular Endocrinology. CrossRef 35 Jennifer Beane, Joshua D Campbell, Julian Lel, Jessica Vick, Avrum Spira. . (2017) Genomic approaches to accelerate cancer interception.
The Lancet Oncology 18:8, e494-e502. CrossRef 36 Barbara Kinga Barták, Alexandra Kalmár, Bálint Péterfia, Árpád V. Patai, Orsolya Galamb, Gábor Valcz, Sándor Spisák, Barnabás Wichmann, Zsófia Brigitta Nagy, Kinga Tóth, Zsolt Tulassay, Péter Igaz, Béla Molnár. . (2017) Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2 , and PRIMA1 in plasma samples.
Epigenetics 142, 1-13. CrossRef 37 Yunbao Pan, Guohong Liu, Fuling Zhou, Bojin Su, Yirong Li. . (2017) DNA methylation profiles in cancer diagnosis and therapeutics. Clinical and Experimental Medicine 23. CrossRef 38 Agne Krilaviciute, Christian Stock, Hermann Brenner. . (2017) International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening.
International Journal of Cancer 1. CrossRef 39 Tsuyoshi Hata, Ichiro Takemasa, Hidekazu Takahashi, Naotsugu Haraguchi, Junichi Nishimura, Taishi Hata, Tsunekazu Mizushima, Yuichiro Doki, Masaki Mori. . (2017) Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer. British Journal of Cancer 117:2, 227-232. CrossRef 40 Bhuvan Molparia, Eshaan Nichani, Ali Torkamani, Alvaro Galli.
. (2017) Assessment of circulating copy number variant detection for cancer screening. PLOS ONE 12:7, e0180647. CrossRef 41 Duncan C. Thomas. . (2017) Estimating the Effect of Targeted Screening Strategies. Epidemiology 28:4, 470-478. CrossRef 42 Duncan C. Thomas. . (2017) What Does “Precision Medicine” Have to Say About Prevention?. Epidemiology 28:4, 479-483. CrossRef 43 Douglas K. Rex, C.
Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, Theodore R. Levin, David Lieberman, Douglas J. Robertson. . (2017) Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointestinal Endoscopy 86:1, 18-33. CrossRef 44 Douglas K. Rex, C. Richard Boland, Jason A. Dominitz, Francis M.
Giardiello, David A. Johnson, Tonya Kaltenbach, Theodore R. Levin, David Lieberman, Douglas J. Robertson. . (2017) Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology 153:1, 307-323. CrossRef 45 Douglas K Rex, C Richard Boland, Jason A Dominitz, Francis M Giardiello, David A Johnson, Tonya Kaltenbach, Theodore R Levin, David Lieberman, Douglas J Robertson.
. (2017) Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. The American Journal of Gastroenterology 112:7, 1016-1030. CrossRef 46 Manuel Zorzi, Carlo Senore, Filippo Da Re, Alessandra Barca, Luigina Ada Bonelli, Renato Cannizzaro, Giovanni de Pretis, Lucia Di Furia, Emilio Di Giulio, Paola Mantellini, Carlo Naldoni, Romano Sassatelli, Douglas K Rex, Marco Zappa, Cesare Hassan.
. (2017) Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut 66:7, 1233-1240. CrossRef 47 James E East, Wendy S Atkin, Adrian C Bateman, Susan K Clark, Sunil Dolwani, Shara N Ket, Simon J Leedham, Perminder S Phull, Matt D Rutter, Neil A Shepherd, Ian Tomlinson, Colin J Rees.
. (2017) British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut 66:7, 1181-1196. CrossRef 48 Iris Lansdorp-Vogelaar, S. Lucas Goede, Linda J.W. Bosch, Veerle Melotte, Beatriz Carvalho, Manon van Engeland, Gerrit A. Meijer, Harry J. de Koning, Marjolein van Ballegooijen. . (2017) Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
Clinical Gastroenterology and Hepatology. CrossRef 49 Paul D Wagner. . 2017. Colon Cancer. Biomarkers in Cancer Screening and Early Detection, 141-150. CrossRef 50 Shashwat Sharad, Taduru Sreenath, Shiv Srivastava, Albert Dobi. . 2017. Cancer Genome Methylation: Biology, Biomarker and Therapeutic Opportunities. Biomarkers in Cancer Screening and Early Detection, 16-26. CrossRef 51 Sharmistha Ghosh, Sudhir Srivastava.
. 2017. Nuts and Bolts of Biomarker Research. Biomarkers in Cancer Screening and Early Detection, 1-15. CrossRef 52 Jesse Samuel Moore, Tess Hannah Aulet. . (2017) Colorectal Cancer Screening. Surgical Clinics of North America 97:3, 487-502. CrossRef 53 Li-Chun Chang, Chia-Tung Shun, Weng-Feng Hsu, Chia-Hong Tu, Pei-Yu Tsai, Been-Ren Lin, Jin-Tung Liang, Ming-Shiang Wu, Han-Mo Chiu. . (2017) Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of Sensitivity.
Clinical Gastroenterology and Hepatology 15:6, 872-879.e1. CrossRef 54 Joseph C. Anderson, Douglas J. Robertson. . (2017) Serrated Polyp Detection by the Fecal Immunochemical Test: An Imperfect FIT. Clinical Gastroenterology and Hepatology 15:6, 880-882. CrossRef 55 Tobias Niedermaier, Korbinian Weigl, Michael Hoffmeister, Hermann Brenner. . (2017) Diagnostic performance of flexible sigmoidoscopy combined with fecal immunochemical test in colorectal cancer screening: meta-analysis and modeling.
European Journal of Epidemiology 32:6, 481-493. CrossRef 56 Hermann Brenner, Tobias Niedermaier, Hongda Chen. . (2017) Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin. International Journal of Cancer 140:9, 2015-2022. CrossRef 57 Afsaneh Barzi, Heinz-Josef Lenz, David I. Quinn, Sarmad Sadeghi. . (2017) Comparative effectiveness of screening strategies for colorectal cancer.
Cancer 123:9, 1516-1527. CrossRef 58 Lila J. Finney Rutten, Robert M. Jacobson, Patrick M. Wilson, Debra J. Jacobson, Chun Fan, John B. Kisiel, Seth Sweetser, Sidna M. Tulledge-Scheitel, Jennifer L. St. Sauver. . (2017) Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening. Mayo Clinic Proceedings 92:5, 726-733. CrossRef 59 Lele Song, Xiumei Peng, Yuemin Li, Wenhua Xiao, Jia Jia, Cheng Dong, Yuan Gong, Guangpeng Zhou, Xiaoliang Han.
. (2017) The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening. Epigenomics 9:5, 599-610. CrossRef 60 Samir Gupta, Jesse Nodora. . (2017) Optimizing the Quality of the Colorectal Cancer Screening Continuum: A Call to Action. JNCI: Journal of the National Cancer Institute 109:5. CrossRef 61 H?ctor Quezada, Ana Laura Guzm?n-Ortiz, Hugo D?az-S?nchez, Ricardo Valle-Rios, Jes?s Aguirre-Hern?ndez.
. (2017) Omics-based biomarkers: current status and potential use in the clinic. Bolet?n M?dico del Hospital Infantil de M?xico 74:3, 219-226. CrossRef 62 Lele Song, Yuemin Li. . (2017) Progress on the clinical application of the SEPT9 gene methylation assay in the past 5 years. Biomarkers in Medicine 11:6, 415-418. CrossRef 63 Steven H. Itzkowitz, David A. Ahlquist. . (2017) The Case for a Multitarget Stool DNA Test: A Closer Look at the Cost Effectiveness Model.
Gastroenterology 152:6, 1620-1621. CrossRef 64 Uri Ladabaum, Ajitha Mannalithara. . (2017) Reply. Gastroenterology 152:6, 1621-1622. CrossRef 65 C Nadal, T Winder, A Gerger, David Tougeron. . (2017) Future perspectives of circulating tumor DNA in colorectal cancer. Tumor Biology 39:5, 101042831770574. CrossRef 66 (2017) Screening for Colorectal Neoplasia. New England Journal of Medicine 376:16, 1598-1600.
Free Full Text 67 Perry J. Pickhardt, Ifeanyi Mbah, B. Dustin Pooler, Oliver T. Chen, J. Louis Hinshaw, Jennifer M. Weiss, David H. Kim. . (2017) CT Colonographic Screening of Patients With a Family History of Colorectal Cancer: Comparison With Adults at Average Risk and Implications for Guidelines. American Journal of Roentgenology 208:4, 794-800. CrossRef 68 Xiao Han, Junyun Wang, Yingli Sun.
. (2017) Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics, Proteomics & Bioinformatics. CrossRef 69 Douglas J. Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas K. Rex. . (2017) Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
Gastroenterology 152:5, 1217-1237.e3. CrossRef 70 Junyun Wang, Xiao Han, Yingli Sun. . (2017) DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer. Science China Life Sciences 60:4, 356-362. CrossRef 71 Keigo Yokoi, Keishi Yamashita, Masahiko Watanabe. . (2017) Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
International Journal of Molecular Sciences 18:4, 735. CrossRef 72 Theodore R Levin. . (2017) In simulation modelling, there are multiple ways to effectively screen for colorectal cancer. Evidence Based Medicine 22:2, 59-59. CrossRef 73 Yutaka Suehiro, Yibo Zhang, Shinichi Hashimoto, Taro Takami, Shingo Higaki, Yoshitaro Shindo, Nobuaki Suzuki, Shoichi Hazama, Masaaki Oka, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki.
. (2017) Highly sensitive faecal DNA testing of TWIST1 methylation in combination with faecal immunochemical test for haemoglobin is a promising marker for detection of colorectal neoplasia. Annals of Clinical Biochemistry 49, 000456321769106. CrossRef 74 Seohui Lee, Byeong Gwan Kim, Ji Won Kim, Kook Lae Lee, Dae Lim Koo, Hyunwoo Nam, Jong Pil Im, Joo Sung Kim, Seong-Joon Koh. . (2017) Obstructive sleep apnea is associated with an increased risk of colorectal neoplasia.
Gastrointestinal Endoscopy 85:3, 568-573.e1. CrossRef 75 David H. Johnson, John B. Kisiel, Kelli N. Burger, Douglas W. Mahoney, Mary E. Devens, David A. Ahlquist, Seth Sweetser. . (2017) Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening. Gastrointestinal Endoscopy 85:3, 657-665.e1. CrossRef 76 Theodore R. Levin, Douglas A.
Corley, Christopher D. Jensen, Amy R. Marks, Wei K. Zhao, Alexis M. Zebrowski, Virginia P. Quinn, Lawrence W. Browne, William R. Taylor, David A. Ahlquist, Graham P. Lidgard, Barry M. Berger. . (2017) Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Digestive Diseases and Sciences 62:3, 678-688. CrossRef 77 Anuli Christiana Uzozie, Nathalie Selevsek, Asa Wahlander, Paolo Nanni, Jonas Grossmann, Achim Weber, Federico Buffoli, Giancarlo Marra.
. (2017) Targeted Proteomics for Multiplexed Verification of Markers of Colorectal Tumorigenesis. Molecular & Cellular Proteomics 16:3, 407-427. CrossRef 78 Otis W. Brawley. . 2017. Cancer Screening and Early Detection. Holland-Frei Cancer Medicine, 1-19. CrossRef 79 Roshni D. Kalachand, Bryan T. Hennessy, Robert C. Bast, Gordon B. Mills. . 2017. Molecular Diagnostics in Cancer. Holland-Frei Cancer Medicine, 1-14.
CrossRef 80 Jane V Carter, Norman J Galbraith, Dongyan Yang, James F Burton, Samuel P Walker, Susan Galandiuk. . (2017) Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis. British Journal of Cancer 9. CrossRef 81 Youngjee Choi, Heather F. Sateia, Kimberly S. Peairs, Rosalyn W. Stewart. . (2017) Screening for colorectal cancer. Seminars in Oncology 44:1, 34-44.
CrossRef 82 Solomon, Caren G.Inadomi, John M.. (2017) Screening for Colorectal Neoplasia. New England Journal of Medicine 376:2, 149-156.Full Text 83 Mohamad M. Kronfol, Mikhail G. Dozmorov, Rong Huang, Patricia W. Slattum, Joseph L. McClay. . (2017) The role of epigenomics in personalized medicine. Expert Review of Precision Medicine and Drug Development 2:1, 33-45. CrossRef 84 Douglas J.
Robertson, Jeffrey K. Lee, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas K. Rex. . (2017) Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastrointestinal Endoscopy 85:1, 2-21.e3. CrossRef 85 Gunter Weiss, Anne Schlegel, Denise Kottwitz, Thomas König, Reimo Tetzner.
. (2017) Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease. Journal of Thoracic Oncology 12:1, 77-84. CrossRef 86 Yutaka Suehiro, Kouhei Sakai, Mitsuaki Nishioka, Shinichi Hashimoto, Taro Takami, Shingo Higaki, Yoshitaro Shindo, Shoichi Hazama, Masaaki Oka, Hiroaki Nagano, Isao Sakaida, Takahiro Yamasaki.
. (2017) Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population. Annals of Clinical Biochemistry 54:1, 86-91. CrossRef 87 Brandon W. Heimer, Brooke E. Tam, Alissa Minkovsky, Hadley D. Sikes. . (2017) Using nanobiotechnology to increase the prevalence of epigenotyping assays in precision medicine. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 9:1, e1407.
CrossRef 88 Douglas J Robertson, Jeffrey K Lee, C Richard Boland, Jason A Dominitz, Francis M Giardiello, David A Johnson, Tonya Kaltenbach, David Lieberman, Theodore R Levin, Douglas K Rex. . (2017) Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. The American Journal of Gastroenterology 112:1, 37-53.
CrossRef 89 Theodore R Levin. . (2017) Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. The American Journal of Gastroenterology 112:1, 8-10. CrossRef 90 Xiaotong Hu, Shuiping Liu. . 2017. Epigenetic Biomarkers. Handbook of Epigenetics, 277-292. CrossRef 91 Hiromu Suzuki, Eiichiro Yamamoto, Hiroshi Nakase, Tamotsu Sugai. . 2017. DNA and Histone Methylation in Colon Cancer.
DNA and Histone Methylation as Cancer Targets, 461-487. CrossRef 92 Mark Prince, Lynn Lester, Rupal Chiniwala, Barry Berger. . (2017) Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients. World Journal of Gastroenterology 23:3, 464. CrossRef 93 Rachael J. Werner, Andrew D. Kelly, Jean-Pierre J. Issa. . (2017) Epigenetics and Precision Oncology.
The Cancer Journal 23:5, 262-269. CrossRef 94 Marek Waluga, Michał Żorniak. . 2017. Patient’s Guide in Colorectal Cancer: Observation After Treatment and Treatment of Relapse. Introduction to Gastrointestinal Diseases Vol. 2, 167-176. CrossRef 95 , S.A. Moshkovskii. . (2017) Omics biomarkers and early diagnostics. Biomeditsinskaya Khimiya 63:5, 369-372. CrossRef 96 J. Tost, I.G. Gut. .
2017. Molecular Techniques for DNA Methylation Studies. Molecular Diagnostics, 103-139. CrossRef 97 Soo-Kyung Park, Hae Lim Baek, Junghee Yu, Ji Yeon Kim, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Hungdai Kim, Hyung Ook Kim, Kyung Uk Jeong, Ho-Kyung Chun, Kyungeun Kim, Dong Il Park. . (2017) Is methylation analysis of SFRP2 , TFPI2 , NDRG4 , and BMP3 promoters suitable for colorectal cancer screening in the Korean population?.
Intestinal Research 15:4, 495. CrossRef 98 Xiaofei Zhi, Jinqiu Tao, Lei Zhang, Ran Tao, Lilin Ma, Jun Qin. . (2016) Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer. Cell Death and Disease 7:12, e2569. CrossRef 99 Eric P. van der Stok, Manon C. W. Spaander, Dirk J. Grünhagen, Cornelis Verhoef, Ernst J.
Kuipers. . (2016) Surveillance after curative treatment for colorectal cancer. Nature Reviews Clinical Oncology 14:5, 297-315. CrossRef 100 Muriel X. G. Draht, Kim M. Smits, Valérie Jooste, Benjamin Tournier, Martijn Vervoort, Chantal Ramaekers, Caroline Chapusot, Matty P. Weijenberg, Manon van Engeland, Veerle Melotte. . (2016) Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
Clinical Epigenetics 8:1. CrossRef 101 Nielson T. Baxter, Mack T. Ruffin, Mary A. M. Rogers, Patrick D. Schloss. . (2016) Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Medicine 8:1. CrossRef 102 Nielson T. Baxter, Charles C. Koumpouras, Mary A. M. Rogers, Mack T. Ruffin, Patrick D. Schloss. . (2016) DNA from fecal immunochemical test can replace stool for detection of colonic lesions using a microbiota-based model.
Microbiome 4:1. CrossRef 103 W. Gu, E. D. Crawford, B. D. O’Donovan, M. R. Wilson, E. D. Chow, H. Retallack, J. L. DeRisi. . (2016) Depletion of Abundant Sequences by Hybridization (DASH): using Cas9 to remove unwanted high-abundance species in sequencing libraries and molecular counting applications. Genome Biology 17:1. CrossRef 104 Yu-Ligh Liou, Tao-Lan Zhang, Tian Yan, Ching-Tung Yeh, Ya-Nan Kang, Lanqin Cao, Nayiyuan Wu, Chi-Feng Chang, Huei-Jen Wang, Carolyn Yen, Tang-Yuan Chu, Yi Zhang, Yu Zhang, Honghao Zhou.
. (2016) Combined clinical and genetic testing algorithm for cervical cancer diagnosis. Clinical Epigenetics 8:1. CrossRef 105 John B. Kisiel, Gauree G. Konijeti, Andrew J. Piscitello, Tarun Chandra, Thomas F. Goss, David A. Ahlquist, Francis A. Farraye, Ashwin N. Ananthakrishnan. . (2016) Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis.
Clinical Gastroenterology and Hepatology 14:12, 1778-1787.e8. CrossRef 106 Els Wieten, Eline H. Schreuders, Stella A.V. Nieuwenburg, Bettina E. Hansen, Iris Lansdorp-Vogelaar, Ernst J. Kuipers, Marco J. Bruno, Manon C.W. Spaander. . (2016) Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program. Clinical Gastroenterology and Hepatology 14:12, 1771-1777.
CrossRef 107 Indraneil Mukherjee, Brett Powell, Mary Parianos, Darrell Downs, Sharona B. Ross. . (2016) Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer. Cancer Genetics 209:12, 582-591. CrossRef 108 Tommaso A. Dragani, Antoni Castells, Vathany Kulasingam, Eleftherios P. Diamandis, Helena Earl, Wade T. Iams, Christine M. Lovly, J. P. Michiel Sedelaar, Jack A.
Schalken. . (2016) Major milestones in translational oncology. BMC Medicine 14:1. CrossRef 109 Bipasa Biswas. . (2016) Clinical Performance Evaluation of Molecular Diagnostic Tests. The Journal of Molecular Diagnostics 18:6, 803-812. CrossRef 110 S. Calvin Thigpen, Stephen A. Geraci. . (2016) Cancer Screening 2016. The American Journal of the Medical Sciences 352:5, 493-501. CrossRef 111 Wei Shi, Zhihua Ye, Li Zhuang, Yingchang Li, Wendi Shuai, Zhixiang Zuo, Xueli Mao, Ranyi Liu, Jiangxue Wu, Shuai Chen, Wenlin Huang.
. (2016) Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells. The Journal of Pathology 240:3, 352-365. CrossRef 112 F. T. Kolligs. . (2016) Vorsorge des kolorektalen Karzinoms. Der Gastroenterologe 11:6, 444-455. CrossRef 113 (2016) The Proceedings of Medical Quality 2016. American Journal of Medical Quality 31:2_suppl, 5S-28S.
CrossRef 114 Ian A Cree. . (2016) Progress and potential of RAS mutation detection for diagnostics and companion diagnostics. Expert Review of Molecular Diagnostics 16:10, 1067-1072. CrossRef 115 Noemi Bellassai, Giuseppe Spoto. . (2016) Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer. Analytical and Bioanalytical Chemistry 408:26, 7255-7264. CrossRef 116 Lin Liu, Karen Messer, John A.
Baron, David A. Lieberman, Elizabeth T. Jacobs, Amanda J. Cross, Gwen Murphy, Maria Elena Martinez, Samir Gupta. . (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes & Control 27:10, 1175-1185. CrossRef 117 Reinier G.S. Meester, Ann G. Zauber, Chyke A. Doubeni, Christopher D. Jensen, Virginia P. Quinn, Mark Helfand, Jason A. Dominitz, Theodore R. Levin, Douglas A.
Corley, Iris Lansdorp-Vogelaar. . (2016) Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clinical Gastroenterology and Hepatology 14:10, 1445-1451.e8. CrossRef 118 Jane V. Carter, Henry L. Roberts, Jianmin Pan, Jonathan D. Rice, James F. Burton, Norman J. Galbraith, Maurice R. Eichenberger, Jeffery Jorden, Peter Deveaux, Russell Farmer, Anna Williford, Ziad Kanaan, Shesh N.
Rai, Susan Galandiuk. . (2016) A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA. Annals of Surgery 264:4, 575-584. CrossRef 119 David L. Keller. . (2016) Patients Have a Right to All Their Medical Test Results. The American Journal of Medicine 129:10, e233-e234. CrossRef 120 Ziad Kanaan, Fadi Antaki. . (2016) CA11-19: a promising marker for the detection of colorectal cancer.
Gastrointestinal Endoscopy 84:4, 753-754. CrossRef 121 Bergein F. Overholt, Donald J. Wheeler, Tommye Jordan, Herbert A. Fritsche. . (2016) Response:. Gastrointestinal Endoscopy 84:4, 754. CrossRef 122 (2016) UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 4:5_suppl, A157-A720. CrossRef 123 Avrum Spira, Mary L. Disis, John T. Schiller, Eduardo Vilar, Timothy R.
Rebbeck, Rafael Bejar, Trey Ideker, Janine Arts, Matthew B. Yurgelun, Jill P. Mesirov, Anjana Rao, Judy Garber, Elizabeth M. Jaffee, Scott M. Lippman. . (2016) Leveraging premalignant biology for immune-based cancer prevention. Proceedings of the National Academy of Sciences 113:39, 10750-10758. CrossRef 124 Soo-Kyung Park, Chang Seok Song, Hyo-Joon Yang, Yoon Suk Jung, Kyu Yong Choi, Dong Hoe Koo, Kyung Eun Kim, Kyung Uk Jeong, Hyung Ook Kim, Hungdai Kim, Ho-Kyung Chun, Dong Il Park.
. (2016) Field Cancerization in Sporadic Colon Cancer. Gut and Liver 10:5, 773-780. CrossRef 125 Masau Sekiguchi, Takahisa Matsuda, Yutaka Saito. . (2016) Surveillance after endoscopic and surgical resection of colorectal cancer. Best Practice & Research Clinical Gastroenterology. CrossRef 126 Barry M. Berger, Paul C. Schroy, Tuan A. Dinh. . (2016) Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
Clinical Colorectal Cancer 15:3, e65-e74. CrossRef 127 Uri Ladabaum, Ashley Patel, Ajitha Mannalithara, Vandana Sundaram, Aya Mitani, Manisha Desai. . (2016) Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool. Cancer 122:17, 2663-2670. CrossRef 128 Joshua C. Obuch, Dennis J. Ahnen. . (2016) Colorectal Cancer.
Gastroenterology Clinics of North America 45:3, 459-476. CrossRef 129 Uri Ladabaum, Ajitha Mannalithara. . (2016) Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia. Gastroenterology 151:3, 427-439.e6. CrossRef 130 Lisa Dickerson, Susan Combs Varcak. . (2016) Colorectal cancer screening. Journal of the American Academy of Physician Assistants 29:9, 1-3.
CrossRef 131 Perry J. Pickhardt. . (2016) Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: the importance of cancer prevention in addition to cancer detection. Abdominal Radiology 41:8, 1441-1444. CrossRef 132 C. P. Pox, F. Kühn, E. Klar. . (2016) Darmkrebsfrüherkennung. Der Onkologe 22:8, 529-536. CrossRef 133 (2016) Colorectal Adenomas. New England Journal of Medicine 375:4, 387-390.
Free Full Text 134 Carrie Printz. . (2016) Noninvasive test detects colorectal cancer in previously unscreened patients. Cancer 122:14, 2129-2129. CrossRef 135 David E. Amacher. . (2016) A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers 21:5, 387-403. CrossRef 136 David H. Johnson, William R. Taylor, Mohammed M. Aboelsoud, Patrick H.
Foote, Tracy C. Yab, Xiaoming Cao, Thomas C. Smyrk, Edward V. Loftus, Douglas W. Mahoney, David A. Ahlquist, John B. Kisiel. . (2016) DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohnʼs Colitis. Inflammatory Bowel Diseases 22:7, 1559-1567. CrossRef 137 Veronika I. Butvilovskaya, Sofya B. Popletaeva, Vladimir R. Chechetkin, Zhanna I. Zubtsova, Marya V. Tsybulskaya, Larisa O.
Samokhina, Leonid I. Vinnitskii, Aligeydar A. Ragimov, Elena I. Pozharitskaya, Galina A. Grigor´eva, Natalya Y. Meshalkina, Svetlana V. Golysheva, Nadezhda V. Shilova, Nicolai V. Bovin, Aleksander S. Zasedatelev, Alla Y. Rubina. . (2016) Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Medicine 5:7, 1361-1372. CrossRef 138 Gemma Armengol, Virinder K.
Sarhadi, Reza Ghanbari, Masoud Doghaei-Moghaddam, Reza Ansari, Masoud Sotoudeh, Pauli Puolakkainen, Arto Kokkola, Reza Malekzadeh, Sakari Knuutila. . (2016) Driver Gene Mutations in Stools of Colorectal Carcinoma Patients Detected by Targeted Next-Generation Sequencing. The Journal of Molecular Diagnostics 18:4, 471-479. CrossRef 139 Olalla Otero-Estévez, Loretta De Chiara, Leticia Barcia-Castro, María Páez de la Cadena, Francisco Javier Rodríguez-Berrocal, Joaquín Cubiella, Vicent Hernández, Vicenta Soledad Martínez-Zorzano.
. (2016) Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer. Scientific Reports 6:1. CrossRef 140 Eihab Abdelfatah, Zachary Kerner, Nainika Nanda, Nita Ahuja. . (2016) Epigenetic therapy in gastrointestinal cancer: the right combination. Therapeutic Advances in Gastroenterology 9:4, 560-579. CrossRef 141 Tobias Niedermaier, Korbinian Weigl, Michael Hoffmeister, Hermann Brenner.
. (2016) Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review. Clinical and Translational Gastroenterology 7:6, e175. CrossRef 142 Maria Golato, Marco Moretti, Stefano Martinotti, Elena Maria Toniato, Massimiliano Bonafè, Beatrice Caruso, Marika Caruso, Marzia Cozzi, Vincenzo De Iuliis, Romolo Marco Dorizzi, Mario Laneve, Franca Maria Lattanzio, Myriam Luongo, Maria Grazia Marin, Sabino Matera, Fabiola Olivieri, Luciano Pasini, Antonio D.
Procopio, Roberto Testa, Emanuela Toffalori, Anna Vero. . (2016) Tumore del colon retto: percorsi diagnostici sulla base di linee guida internazionali. La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine 12:2, 70-80. CrossRef 143 Andrea Iannone, Giuseppe Losurdo, Maria Pricci, Bruna Girardi, Antonio Massaro, Mariabeatrice Principi, Michele Barone, Enzo Ierardi, Alfredo Di Leo.
. (2016) Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis. Journal of Gastrointestinal Cancer 47:2, 143-151. CrossRef 144 Seth Sweetser, David A. Ahlquist. . (2016) Multi-Target Stool DNA Test: Is the Future Here?. Current Gastroenterology Reports 18:6. CrossRef 145 Jeffrey J. Jones, Bruce E. Wilcox, Ryan W. Benz, Naveen Babbar, Genna Boragine, Ted Burrell, Ellen B.
Christie, Lisa J. Croner, Phong Cun, Roslyn Dillon, Stefanie N. Kairs, Athit Kao, Ryan Preston, Scott R. Schreckengaust, Heather Skor, William F. Smith, Jia You, W. Daniel Hillis, David B. Agus, John E. Blume. . (2016) A Plasma-Based Protein Marker Panel for Colorectal Cancer Detection Identified by Multiplex Targeted Mass Spectrometry. Clinical Colorectal Cancer 15:2, 186-194.e13. CrossRef 146 S.
L. Rasmussen, H. B. Krarup, K. G. Sunesen, I. S. Pedersen, P. H. Madsen, O. Thorlacius-Ussing. . (2016) Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review. Colorectal Disease 18:6, 549-561. CrossRef 147 Alexander Hamm, Hans Prenen, Wouter Van Delm, Mario Di Matteo, Mathias Wenes, Estelle Delamarre, Thomas Schmidt, Jürgen Weitz, Roberta Sarmiento, Angelo Dezi, Giampietro Gasparini, Françoise Rothé, Robin Schmitz, André D'Hoore, Hannes Iserentant, Alain Hendlisz, Massimiliano Mazzone.
. (2016) Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer. Gut 65:6, 990-1000. CrossRef 148 Yutaka Hashimoto, Timothy J Zumwalt, Ajay Goel. . (2016) DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer. Epigenomics 8:5, 685-703. CrossRef 149 Antonio Z. Gimeno-García, Noemi Hernández-Álvarez-de-Buylla, David Nicolás-Pérez, Marta Carrillo, Goretti Hernández, Enrique Quintero.
. (2016) Colorectal cancer screening in the familial risk population: Is colonoscopy still the strategy of choice?. Gastroenterología y Hepatología 39:5, 352-360. CrossRef 150 Courtney C. Moreno, Paul S. Weiss, Thomas L. Jarrett, David L. Roberts, Pardeep K. Mittal, John R. Votaw. . (2016) Patient Preferences Regarding Colorectal Cancer Screening: Test Features and Cost Willing to Pay Out of Pocket.
Current Problems in Diagnostic Radiology 45:3, 189-192. CrossRef 151 Antonio Z. Gimeno-García, Noemi Hernández-Álvarez-de-Buylla, David Nicolás-Pérez, Marta Carrillo, Goretti Hernández, Enrique Quintero. . (2016) Colorectal cancer screening in the familial risk population: Is colonoscopy still the strategy of choice?. Gastroenterología y Hepatología (English Edition) 39:5, 352-360. CrossRef 152 Uri Ladabaum, Robert E.
Schoen. . (2016) Post-Polypectomy Surveillance That Would Please Goldilocks—Not Too Much, Not Too Little, but Just Right. Gastroenterology 150:4, 791-796. CrossRef 153 James R. Bailey, Ashish Aggarwal, Thomas F. Imperiale. . (2016) Colorectal Cancer Screening: Stool DNA and Other Noninvasive Modalities. Gut and Liver 10:2, 204. CrossRef 154 Longo, Dan L.Strum, Williamson B.. (2016) Colorectal Adenomas.
New England Journal of Medicine 374:11, 1065-1075.Full Text 155 Graeme P. Young, Carlo Senore, Jack S. Mandel, James E. Allison, Wendy S. Atkin, Robert Benamouzig, Patrick M. M. Bossuyt, Mahinda De Silva, Lydia Guittet, Stephen P. Halloran, Ulrike Haug, Geir Hoff, Steven H. Itzkowitz, Marcis Leja, Bernard Levin, Gerrit A. Meijer, Colm A. O'Morain, Susan Parry, Linda Rabeneck, Paul Rozen, Hiroshi Saito, Robert E.
Schoen, Helen E. Seaman, Robert J. C. Steele, Joseph J. Y. Sung, Sidney J. Winawer. . (2016) Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer. Cancer 122:6, 826-839. CrossRef 156 Eline H. Schreuders, Esmée J. Grobbee, Manon C. W. Spaander, Ernst J. Kuipers. . (2016) Advances in Fecal Tests for Colorectal Cancer Screening. Current Treatment Options in Gastroenterology 14:1, 152-162.
CrossRef 157 Charles J Kahi, C Richard Boland, Jason A Dominitz, Francis M Giardiello, David A Johnson, Tonya Kaltenbach, David Lieberman, Theodore R Levin, Douglas J Robertson, Douglas K Rex. . (2016) Colonoscopy Surveillance after Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. The American Journal of Gastroenterology 111:3, 337-346. CrossRef 158 C.
P. Pox. . (2016) Screening des kolorektalen Karzinoms. coloproctology 38:2, 141-152. CrossRef 159 Theodore R. Levin. . (2016) Colorectal cancer screening: 80% by 2018. Colonoscopists simply cannot do it alone. Gastrointestinal Endoscopy 83:3, 552-554. CrossRef 160 Bergein F. Overholt, Donald J. Wheeler, Tommye Jordan, Herbert A. Fritsche. . (2016) CA11-19: a tumor marker for the detection of colorectal cancer.
Gastrointestinal Endoscopy 83:3, 545-551. CrossRef 161 Charles J. Kahi, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas J. Robertson, Douglas K. Rex. . (2016) Colonoscopy surveillance after colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer. Gastrointestinal Endoscopy 83:3, 489-498.
e10. CrossRef 162 Han-Mo Chiu, Jessica Y.L. Ching, Kai Chun Wu, Rungsun Rerknimitr, Jingnan Li, Deng-Chiang Wu, Khean Lee Goh, Takahisa Matsuda, Hyun-Soo Kim, Rupert Leong, Khay Guan Yeoh, Vui Heng Chong, Jose D. Sollano, Furqaan Ahmed, Jayaram Menon, Joseph J.Y. Sung. . (2016) A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
Gastroenterology 150:3, 617-625.e3. CrossRef 163 Charles J. Kahi, C. Richard Boland, Jason A. Dominitz, Francis M. Giardiello, David A. Johnson, Tonya Kaltenbach, David Lieberman, Theodore R. Levin, Douglas J. Robertson, Douglas K. Rex. . (2016) Colonoscopy Surveillance After Colorectal Cancer Resection: Recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 150:3, 758-768.
e11. CrossRef 164 Pramod Malik. . (2016) A novel multitarget stool DNA test for colorectal cancer screening. Postgraduate Medicine 128:2, 268-272. CrossRef 165 Kinga Tóth, Barbara Kinga Barták, Zsolt Tulassay, Béla Molnár. . (2016) Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis. Expert Review of Molecular Diagnostics 16:2, 239-252. CrossRef 166 Chunyan Wang, Jin H.
Bae, David Yu Zhang. . (2016) Native characterization of nucleic acid motif thermodynamics via non-covalent catalysis. Nature Communications 7, 10319. CrossRef 167 Erin L Symonds, Susanne K Pedersen, Rohan T Baker, David H Murray, Snigdha Gaur, Stephen R Cole, Geetha Gopalsamy, Dileep Mangira, Lawrence C LaPointe, Graeme P Young. . (2016) A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.
Clinical and Translational Gastroenterology 7:1, e137. CrossRef 168 Benjamin B. Strauss, Tracy C. Yab, Helen M. O’Connor, William R. Taylor, Douglas W. Mahoney, Julie A. Simonson, John Christensen, Suresh T. Chari, David A. Ahlquist. . (2016) Fecal Recovery of Ingested Cellular DNA: Implications for Noninvasive Detection of Upper Gastrointestinal Neoplasms. Digestive Diseases and Sciences 61:1, 117-125.
CrossRef 169 Michael A. McDevitt. . 2016. Clinical Applications of Epigenomics. Epigenomics in Health and Disease, 271-295. CrossRef 170 Tian Gao, Hemant K. Roy. . 2016. Spectroscopy. Endoscopic Imaging Techniques and Tools, 175-185. CrossRef 171 R.A. Hlady, K.D. Robertson. . 2016. Use of Chromatin Changes as Biomarkers. Chromatin Signaling and Diseases, 403-421. CrossRef 172 Rachel Baldwin-Cleland, Janice Muckian.
. 2016. Overview of CTC in Imaging the Colon. CT Colonography for Radiographers, 61-73. CrossRef 173 Tandy L.D. Petrov, Nicole C. Riddle. . 2016. The Evolution of New Technologies and Methods in Clinical Epigenetics Research. Epigenetic Biomarkers and Diagnostics, 67-89. CrossRef 174 Jill Tinmouth, Emily T. Vella, Nancy N. Baxter, Catherine Dubé, Michael Gould, Amanda Hey, Nofisat Ismaila, Bronwen R.
McCurdy, Lawrence Paszat. . (2016) Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Canadian Journal of Gastroenterology and Hepatology 2016, 1-18. CrossRef 175 Diana G. Redwood, Elvin D. Asay, Ian D. Blake, Pamela E. Sacco, Claudia M. Christensen, Frank D. Sacco, James J. Tiesinga, Mary E. Devens, Steven R. Alberts, Douglas W. Mahoney, Tracy C. Yab, Patrick H. Foote, Thomas C.
Smyrk, Ellen M. Provost, David A. Ahlquist. . (2016) Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People. Mayo Clinic Proceedings 91:1, 61-70. CrossRef 176 Haitham Amal, Marcis Leja, Konrads Funka, Ieva Lasina, Roberts Skapars, Armands Sivins, Guntis Ancans, Ilze Kikuste, Aigars Vanags, Ivars Tolmanis, Arnis Kirsners, Limas Kupcinskas, Hossam Haick. . (2016) Breath testing as potential colorectal cancer screening tool.
International Journal of Cancer 138:1, 229-236. CrossRef 177 I. E. Khatkov, A. V. Kagramanova, N. B. Zakharzhevskaya, E. A. Babikova, E. V. Generozov, P. L. Shcherbakov, A. I. Parfenov. . (2016) Current principles in the screening, diagnosis, and therapy of colorectal cancer. Terapevticheskii arkhiv 88:2, 90. CrossRef 178 Yuji Toiyama, Yasuhiro Inoue, Masato Kusunoki. . (2016) Molecular Diagnosis of Colorectal Cancer.
Nippon Daicho Komonbyo Gakkai Zasshi 69:10, 480-488. CrossRef 179 Hans-Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg, Hans Raskov. . (2016) Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial. Gastroenterology 150:1, 114-122.e4. CrossRef 180 Fares Al-Ejeh, Andrew V. Biankin. . 2016. Molecular Diagnostics: Translation from Discovery to Clinical Practice.
Molecular Pathology in Cancer Research, 1-26. CrossRef 181 Stewart N Bonnington. . (2016) Surveillance of colonic polyps: Are we getting it right?. World Journal of Gastroenterology 22:6, 1925. CrossRef 182 B. E. Tam, K. Sung, H. D. Sikes. . (2016) Engineering affinity agents for the detection of hemi-methylated CpG sites in DNA. Molecular Systems Design & Engineering 1:3, 273-277. CrossRef 183 Susanne K.
Pedersen, Erin L. Symonds, Rohan T. Baker, David H. Murray, Aidan McEvoy, Sascha C. Van Doorn, Marco W. Mundt, Stephen R. Cole, Geetha Gopalsamy, Dileep Mangira, Lawrence C. LaPointe, Evelien Dekker, Graeme P. Young. . (2015) Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer 15:1. CrossRef 184 Meng Xue, San Chuan Lai, Zhi Peng Xu, Liang Jing Wang.
. (2015) Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review. Journal of Digestive Diseases 16:12, 699-712. CrossRef 185 M.Á. Onieva-García, A. Llanos-Méndez, E. Baños-Álvarez, R. Isabel-Gómez. . (2015) Validez clínica de la prueba genética CologuardTM para el cribado de cáncer colorrectal: revisión sistemática. Revista Clínica Española 215:9, 527-536. CrossRef 186 M.
Á. Onieva-García, A. Llanos-Méndez, E. Baños-Álvarez, R. Isabel-Gómez. . (2015) A systematic review of the clinical validity of the Cologuard™ genetic test for screening colorectal cancer. Revista Clínica Española (English Edition) 215:9, 527-536. CrossRef 187 Hermann Brenner, Christian Stock, Michael Hoffmeister. . (2015) Colorectal cancer screening: the time to act is now. BMC Medicine 13:1.
CrossRef 188 Giancarlo Russo, Andrea Patrignani, Lucy Poveda, Frederic Hoehn, Bettina Scholtka, Ralph Schlapbach, Alex M. Garvin. . (2015) Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing. Applied & Translational Genomics 7, 32-39. CrossRef 189 Han-Mo Chiu, Li-Chun Chang, Wen-Feng Hsu, Chu-Kuang Chou, Ming-Shiang Wu.
. (2015) Non-invasive screening for colorectal cancer in Asia. Best Practice & Research Clinical Gastroenterology 29:6, 953-965. CrossRef 190 M. Helen Whited, Swarna S. Chaliki, Erika S. Boroff. . (2015) Going the Distance: Colorectal Cancer Screening in Women. Journal of Women's Health 24:12, 1047-1049. CrossRef 191 Erin L. Symonds, Graeme P. Young. . (2015) Blood Tests for Colorectal Cancer Screening in the Standard Risk Population.
Current Colorectal Cancer Reports 11:6, 397-407. CrossRef 192 Linda Rabeneck, Iris Lansdorp-Vogelaar. . (2015) Assessment of a cancer screening program. Best Practice & Research Clinical Gastroenterology 29:6, 979-985. CrossRef 193 Ramzi Amri, Liliana G. Bordeianou, David L. Berger. . (2015) The conundrum of the young colon cancer patient. Surgery 158:6, 1696-1703. CrossRef 194 Keiko Shinjo, Yutaka Kondo.
. (2015) Targeting cancer epigenetics: Linking basic biology to clinical medicine. Advanced Drug Delivery Reviews 95, 56-64. CrossRef 195 Yolanda TEIXEIRA, Jacqueline Miranda LIMA, Maria Luiza Almeida Prado Oliveira SOUZA, Pedro AGUIAR Jr, Tiago Donizetti SILVA, Nora Manoukian FORONES, . . (2015) HUMAN DNA QUANTIFICATION IN THE STOOLS OF PATIENTS WITH COLORECTAL CANCER. Arquivos de Gastroenterologia 52:4, 293-298.
CrossRef 196 Ugo Fedeli, Manuel Zorzi, Emanuele D.L. Urso, Nicola Gennaro, Angelo P. Dei Tos, Mario Saugo. . (2015) Impact of fecal immunochemical test-based screening programs on proximal and distal colorectal cancer surgery rates: A natural multiple-baseline experiment. Cancer 121:22, 3982-3989. CrossRef 197 Ernst J. Kuipers, William M. Grady, David Lieberman, Thomas Seufferlein, Joseph J.
Sung, Petra G. Boelens, Cornelis J. H. van de Velde, Toshiaki Watanabe. . (2015) Colorectal cancer. Nature Reviews Disease Primers, 15065. CrossRef 198 Linda Rabeneck, Susan Horton, Ann G. Zauber, Craig Earle. . 2015. Colorectal Cancer. Disease Control Priorities, Third Edition (Volume 3): Cancer, 101-119. CrossRef 199 Kjetil Garborg. . (2015) Colorectal Cancer Screening. Surgical Clinics of North America 95:5, 979-989.
CrossRef 200 Takahisa Matsuda, Akiko Ono, Yasuo Kakugawa, Minori Matsumoto, Yutaka Saito. . (2015) Impact of screening colonoscopy on outcomes in colorectal cancer. Japanese Journal of Clinical Oncology 45:10, 900-905. CrossRef 201 Fiona Sim, Caroline Haig, John O’Dowd, Lucy Thompson, James Law, Alex McConnachie, Christopher Gillberg, Philip Wilson. . (2015) Development of a triage tool for neurodevelopmental risk in children aged 30 months.
Research in Developmental Disabilities 45-46, 69-82. CrossRef 202 Douglas J. Robertson, Thomas F. Imperiale. . (2015) Stool Testing for Colorectal Cancer Screening. Gastroenterology 149:5, 1286-1293. CrossRef 203 John M. Carethers, Barbara H. Jung. . (2015) Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer. Gastroenterology 149:5, 1177-1190.e3. CrossRef 204 Zhihua Liu, Liang Kang, Meijin Huang, Yanxin Luo, Lei Wang, Ping Lan, Ji Cui, Jianping Wang.
. (2015) Open Surgery Against Laparoscopic Surgery for Mid-Rectal or Low-Rectal Cancer of Male Patients. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 25:5, 444-448. CrossRef 205 Yun-Suhk Suh, Han-Kwang Yang. . (2015) Screening and Early Detection of Gastric Cancer. Surgical Clinics of North America 95:5, 1053-1066. CrossRef 206 Xuyu Cai, Filip Janku, Qimin Zhan, Jian-Bing Fan.
. (2015) Accessing Genetic Information with Liquid Biopsies. Trends in Genetics 31:10, 564-575. CrossRef 207 Yoshinaga Okugawa, William M. Grady, Ajay Goel. . (2015) Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers. Gastroenterology 149:5, 1204-1225.e12. CrossRef 208 Karna K. Sundsted, Mark L. Wieland, Jason H. Szostek, Jason A. Post, Karen F. Mauck. . (2015) Update in Outpatient General Internal Medicine: Practice-changing Evidence Published in 2014.
The American Journal of Medicine 128:10, 1065-1069. CrossRef 209 Eline H Schreuders, Arlinda Ruco, Linda Rabeneck, Robert E Schoen, Joseph J Y Sung, Graeme P Young, Ernst J Kuipers. . (2015) Colorectal cancer screening: a global overview of existing programmes. Gut 64:10, 1637-1649. CrossRef 210 Tanya Kadiyska, Alexander Nossikoff. . (2015) Stool DNA methylation assays in colorectal cancer screening.
World Journal of Gastroenterology 21:35, 10057-10061. CrossRef 211 Grace Clarke Hillyer, Alfred I. Neugut. . (2015) Where does it FIT? The roles of fecal testing and colonoscopy in colorectal cancer screening. Cancer 121:18, 3186-3189. CrossRef 212 Aurelien Amiot, Anthony C. Dona, Anisha Wijeyesekera, Christophe Tournigand, Isabelle Baumgaertner, Yann Lebaleur, Iradj Sobhani, Elaine Holmes. .
(2015) 1 H NMR Spectroscopy of Fecal Extracts Enables Detection of Advanced Colorectal Neoplasia. Journal of Proteome Research 14:9, 3871-3881. CrossRef 213 John R Ridge, Sandra Statz. . (2015) Exact Sciences’ experience with the FDA and CMS parallel review program. Expert Review of Molecular Diagnostics 15:9, 1117-1124. CrossRef 214 Ryan M. Thomas, Christian Jobin. . (2015) The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real?.
Trends in Cancer 1:1, 24-35. CrossRef 215 Brandon T Dickinson, John Kisiel, David A Ahlquist, William M Grady. . (2015) Molecular markers for colorectal cancer screening. Gut 64:9, 1485-1494. CrossRef 216 Harish R. Cheruku, Abidali Mohamedali, David I. Cantor, Sock Hwee Tan, Edouard C. Nice, Mark S. Baker. . (2015) Transforming growth factor-β, MAPK and Wnt signaling interactions in colorectal cancer.
EuPA Open Proteomics 8, 104-115. CrossRef 217 Jamie N Bakkum-Gamez. . (2015) Repurposing the vaginal tampon for endometrial cancer detection. Biomarkers in Medicine 9:8, 715-717. CrossRef 218 Zhifu Sun, Julie Cunningham, Susan Slager, Jean-Pierre Kocher. . (2015) Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis. Epigenomics 7:5, 813-828.
CrossRef 219 Jörg Tost. . (2015) DNA methylation signatures in circulating cell-free DNA for the monitoring of at-risk populations progressing to lung cancer. EBioMedicine 2:8, 798-799. CrossRef 220 D S Thomas, E-O Fourkala, S Apostolidou, R Gunu, A Ryan, I Jacobs, U Menon, W Alderton, A Gentry-Maharaj, J F Timms. . (2015) Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples.
British Journal of Cancer 113:2, 268-274. CrossRef 221 María A. Núñez-Sánchez, Antonio González-Sarrías, María Romo-Vaquero, Rocío García-Villalba, María V. Selma, Francisco A. Tomás-Barberán, María-Teresa García-Conesa, Juan Carlos Espín. . (2015) Dietary phenolics against colorectal cancer-From promising preclinical results to poor translation into clinical trials: Pitfalls and future needs.
Molecular Nutrition & Food Research 59:7, 1274-1291. CrossRef 222 Barbara J. Kenner, Suresh T. Chari, Deborah F. Cleeter, Vay Liang W. Go. . (2015) Early Detection of Sporadic Pancreatic Cancer. Pancreas 44:5, 686-692. CrossRef 223 D. G. Soares, J. Michels, J. Hadoux, A. Bellesoeur, C. Tlemsani, M.-A. Benderra, J.-P. Lotz. . (2015) Congrès de l’association américaine de recherche contre le cancer — AACR 2015.
Oncologie 17:7-8, 277-298. CrossRef 224 Antoni Castells. . (2015) Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therapeutic Advances in Gastroenterology 8:4, 221-233. CrossRef 225 Chen Chen, Lingli Deng, Siwei Wei, G. A. Nagana Gowda, Haiwei Gu, Elena G. Chiorean, Mohammad Abu Zaid, Marietta L. Harrison, Joseph F. Pekny, Patrick J.
Loehrer, Dabao Zhang, Min Zhang, Daniel Raftery. . (2015) Exploring Metabolic Profile Differences between Colorectal Polyp Patients and Controls Using Seemingly Unrelated Regression. Journal of Proteome Research 14:6, 2492-2499. CrossRef 226 Perry J. Pickhardt. . (2015) Colorectal Carcinoma: What Should the Oncologist Recommend for Screening?. Seminars in Oncology 42:3, 359-361. CrossRef 227 James E East, Michael Vieth, Douglas K Rex.
. (2015) Serrated lesions in colorectal cancer screening: detection, resection, pathology and surveillance. Gut 64:6, 991-1000. CrossRef 228 James J. Goedert, Yangming Gong, Xing Hua, Huanzi Zhong, Yimin He, Peng Peng, Guoqin Yu, Wenjing Wang, Jacques Ravel, Jianxin Shi, Ying Zheng. . (2015) Fecal Microbiota Characteristics of Patients with Colorectal Adenoma Detected by Screening: A Population-based Study.
EBioMedicine 2:6, 597-603. CrossRef 229 Shivaram K. Bhat, James E. East. . (2015) Colorectal cancer: prevention and early diagnosis. Medicine 43:6, 295-298. CrossRef 230 Juexiao Sherry Wang, David Yu Zhang. . (2015) Simulation-guided DNA probe design for consistently ultraspecific hybridization. Nature Chemistry 7:7, 545-553. CrossRef 231 Cassandra Willyard. . (2015) Screening: Early alert.
Nature 521:7551, S4-S5. CrossRef 232 Thomas J Hwang, Lisa Soleymani Lehmann, Aaron S Kesselheim. . (2015) Precision medicine and the FDA's draft guidance on laboratory-developed tests. Nature Biotechnology 33:5, 449-451. CrossRef 233 E. F. Beaber, J. J. Kim, M. M. Schapira, A. N. A. Tosteson, A. G. Zauber, A. M. Geiger, A. Kamineni, D. L. Weaver, J. A. Tiro, . . (2015) Unifying Screening Processes Within the PROSPR Consortium: A Conceptual Model for Breast, Cervical, and Colorectal Cancer Screening.
JNCI Journal of the National Cancer Institute 107:6, djv120-djv120. CrossRef 234 Andrea Leung, Ho Tsoi, Jun Yu. . (2015) Fusobacterium and Escherichia : models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening. Expert Review of Gastroenterology & Hepatology 9:5, 651-657. CrossRef 235 Diego M Marzese, Dave SB Hoon. . (2015) Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer.
Expert Review of Molecular Diagnostics 15:5, 647-664. CrossRef 236 William M. Tierney. . (2015) Colonoscopy Versus Capsule: Sharing the Spotlight. Gastroenterology 148:5, 892-894. CrossRef 237 Douglas K. Rex, Samuel N. Adler, James Aisenberg, Wilmot C. Burch, Cristina Carretero, Yehuda Chowers, Steven A. Fein, Steven E. Fern, Ignacio Fernandez-Urien Sainz, Alexander Fich, Eyal Gal, John C. Horlander, Kim L.
Isaacs, Revital Kariv, Adi Lahat, Wai-Keung Leung, Pramod R. Malik, Doug Morgan, Neofytos Papageorgiou, David P. Romeo, Smita S. Shah, Matti Waterman. . (2015) Accuracy of Capsule Colonoscopy in Detecting Colorectal Polyps in a Screening Population. Gastroenterology 148:5, 948-957.e2. CrossRef 238 Rajvinder Singh, Dileep Mangira, Hiroshi Kawano, Takashia Matsuda. . (2015) Screening colonoscopy in Australia.
Digestive Endoscopy 27, 30-34. CrossRef 239 Andrew A. Plumb, Steve Halligan. . (2015) Colorectal Cancer Screening. Seminars in Roentgenology 50:2, 101-110. CrossRef 240 Jamie N. Bakkum-Gamez, Nicolas Wentzensen, Matthew J. Maurer, Kieran M. Hawthorne, Jesse S. Voss, Trynda N. Kroneman, Abimbola O. Famuyide, Amy C. Clayton, Kevin C. Halling, Sarah E. Kerr, William A. Cliby, Sean C. Dowdy, Benjamin R.
Kipp, Andrea Mariani, Ann L. Oberg, Karl C. Podratz, Viji Shridhar, Mark E. Sherman. . (2015) Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons. Gynecologic Oncology 137:1, 14-22. CrossRef 241 Kim Y. C. Fung, Bruce Tabor, Michael J. Buckley, Ilka K. Priebe, Leanne Purins, Celine Pompeia, Gemma V. Brierley, Trevor Lockett, Peter Gibbs, Jeanne Tie, Paul McMurrick, James Moore, Andrew Ruszkiewicz, Edouard Nice, Timothy E.
Adams, Antony Burgess, Leah J. Cosgrove, Jörg D. Hoheisel. . (2015) Blood-Based Protein Biomarker Panel for the Detection of Colorectal Cancer. PLOS ONE 10:3, e0120425. CrossRef 242 Lukejohn W. Day, Fernando Velayos. . (2015) Colorectal Cancer Screening and Surveillance in the Elderly: Updates and Controversies. Gut and Liver 9:2, 143-151. CrossRef 243 Qiang Feng, Suisha Liang, Huijue Jia, Andreas Stadlmayr, Longqing Tang, Zhou Lan, Dongya Zhang, Huihua Xia, Xiaoying Xu, Zhuye Jie, Lili Su, Xiaoping Li, Xin Li, Junhua Li, Liang Xiao, Ursula Huber-Schönauer, David Niederseer, Xun Xu, Jumana Yousuf Al-Aama, Huanming Yang, Jian Wang, Karsten Kristiansen, Manimozhiyan Arumugam, Herbert Tilg, Christian Datz, Jun Wang.
. (2015) Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nature Communications 6, 6528. CrossRef 244 William M. Grady, Sanford D. Markowitz. . (2015) The Molecular Pathogenesis of Colorectal Cancer and Its Potential Application to Colorectal Cancer Screening. Digestive Diseases and Sciences 60:3, 762-772. CrossRef 245 Charles J. Kahi. . (2015) How Does the Serrated Polyp Pathway Alter CRC Screening and Surveillance?.
Digestive Diseases and Sciences 60:3, 773-780. CrossRef 246 Douglas K. Rex. . (2015) Colonoscopy: The Current King of the Hill in the USA. Digestive Diseases and Sciences 60:3, 639-646. CrossRef 247 Bibb Allen. . (2015) Appropriate Use of Medical Imaging Shouldn’t Always Mean Less Imaging. Journal of the American College of Radiology 12:3, 211-212. CrossRef 248 Martin Brotman. . (2015) Colorectal Cancer Screening Quality, Cost and Practice in an Era of Healthcare Transformation.
Digestive Diseases and Sciences 60:3, 692-697. CrossRef 249 David A. Ahlquist. . (2015) Multi-Target Stool DNA Test: A New High Bar for Noninvasive Screening. Digestive Diseases and Sciences 60:3, 623-633. CrossRef 250 D. Heresbach. . (2015) Dépistage des néoplasies coliques par test fécal immunologique : est-il trop tard ?. Acta Endoscopica 45:3, 133-133. CrossRef 251 Robert S. Bresalier, Scott Kopetz, Dean E.
Brenner. . (2015) Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?. Digestive Diseases and Sciences 60:3, 664-671. CrossRef 252 Perry J. Pickhardt. . (2015) CT Colonography for Population Screening: Ready for Prime Time?. Digestive Diseases and Sciences 60:3, 647-659. CrossRef 253 Ann G. Zauber. . (2015) The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference?.
Digestive Diseases and Sciences 60:3, 681-691. CrossRef 254 Sidney J. Winawer. . (2015) The History of Colorectal Cancer Screening: A Personal Perspective. Digestive Diseases and Sciences 60:3, 596-608. CrossRef 255 B. Joseph Elmunzer, Amit G. Singal, Jeremy B. Sussman, Amar R. Deshpande, Daniel A. Sussman, Marisa L. Conte, Ben A. Dwamena, Mary A.M. Rogers, Philip S. Schoenfeld, John M. Inadomi, Sameer D.
Saini, Akbar K. Waljee. . (2015) Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: a network meta-analysis. Gastrointestinal Endoscopy 81:3, 700-709.e3. CrossRef 256 Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. . (2015) Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians 65:2, 87-108.
CrossRef 257 T. Aparicio. . (2015) Quoi de neuf pour l’adénocarcinome colorectal depuis la fin du dernier millénaire ?. Côlon & Rectum 9:1, 19-24. CrossRef 258 Margriet C de Haan, Perry J Pickhardt, Jaap Stoker. . (2015) CT colonography: accuracy, acceptance, safety and position in organised population screening. Gut 64:2, 342-350. CrossRef 259 Caroline Coghlin, Graeme I. Murray.
. (2015) Biomarkers of colorectal cancer: Recent advances and future challenges. PROTEOMICS - Clinical Applications 9:1-2, 64-71. CrossRef 260 Sally C. Benton, Helen E. Seaman, Stephen P. Halloran. . (2015) Faecal Occult Blood Testing for Colorectal Cancer Screening: the Past or the Future. Current Gastroenterology Reports 17:2. CrossRef 261 Toshio Uraoka, Naoki Hosoe, Naohisa Yahagi. . (2015) Colonoscopy: is it as effective as an advanced diagnostic tool for colorectal cancer screening?.
Expert Review of Gastroenterology & Hepatology 9:2, 129-132. CrossRef 262 Caryn S. Ross-Innes, Irene Debiram-Beecham, Maria O'Donovan, Elaine Walker, Sibu Varghese, Pierre Lao-Sirieix, Laurence Lovat, Michael Griffin, Krish Ragunath, Rehan Haidry, Sarmed S. Sami, Philip Kaye, Marco Novelli, Babett Disep, Richard Ostler, Benoit Aigret, Bernard V. North, Pradeep Bhandari, Adam Haycock, Danielle Morris, Stephen Attwood, Anjan Dhar, Colin Rees, Matthew D.
D. Rutter, Peter D. Sasieni, Rebecca C. Fitzgerald, , Eduardo L. Franco. . (2015) Evaluation of a Minimally Invasive Cell Sampling Device Coupled with Assessment of Trefoil Factor 3 Expression for Diagnosing Barrett's Esophagus: A Multi-Center Case–Control Study. PLOS Medicine 12:1, e1001780. CrossRef 263 Maria Gonzalez-Pons, Marcia Cruz-Correa. . (2015) Colorectal Cancer Biomarkers: Where Are We Now?.
BioMed Research International 2015, 1-14. CrossRef 264 B. A. Leggett, D. G. Hewett. . (2015) Colorectal cancer screening. Internal Medicine Journal 45:1, 6-15. CrossRef 265 Lele Song, Yuemin Li. . 2015. SEPT9. Advances in Clinical Chemistry, 171-204. CrossRef 266 Li-Xia Peng, Chao-Nan Qian. . 2015. Nasopharyngeal Cancer. Epigenetic Cancer Therapy, 373-389. CrossRef 267 Louis P. Watanabe, Nicole C.
Riddle. . 2015. Interindividual Variability of DNA Methylation. Personalized Epigenetics, 17-53. CrossRef 268 (2015) Un nouveau test de dépistage du CCR. Revue Francophone des Laboratoires 2015:468, 22. CrossRef 269 Benjamin L. Gordon, Brendan M. Finnerty, Anna Aronova, Thomas J. Fahey. . (2015) Genomic medicine for cancer diagnosis. Journal of Surgical Oncology 111:1, 24-30. CrossRef 270 Justin L.
Sovich, Zachary Sartor, Subhasis Misra. . (2015) Developments in Screening Tests and Strategies for Colorectal Cancer. BioMed Research International 2015, 1-11. CrossRef 271 Robert A. Smith, Deana Manassaram-Baptiste, Durado Brooks, Mary Doroshenk, Stacey Fedewa, Debbie Saslow, Otis W. Brawley, Richard Wender. . (2015) Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening.
CA: A Cancer Journal for Clinicians 65:1, 30-54. CrossRef 272 L. Bonelli. . (2015) Epidemiology and screening: what's new?. Colorectal Disease 17, 10-14. CrossRef 273 Jeremy R Huddy. . (2015) Point-of-care testing in the diagnosis of gastrointestinal cancers: Current technology and future directions. World Journal of Gastroenterology 21:14, 4111. CrossRef 274 A. Lopez, S. Manfredi, J. Faivre.
. (2014) Le dépistage du cancer colorectal. Oncologie 16:11-12, 491-498. CrossRef 275 Timothy M. Barrow, Karin B. Michels. . (2014) Epigenetic epidemiology of cancer. Biochemical and Biophysical Research Communications 455:1-2, 70-83. CrossRef 276 Li-Chun Chang, Han-Mo Chiu, Chia-Tung Shun, Jin-Tung Liang, Jaw-Town Lin, Chien-Chuan Chen, Yi-Chia Lee, Ming-Shiang Wu. . (2014) Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA.
BMC Gastroenterology 14:1. CrossRef 277 Britt K. Erickson, Isaac Kinde, Zachary C. Dobbin, Yuxuan Wang, Jovana Y. Martin, Ronald D. Alvarez, Michael G. Conner, Warner K. Huh, Richard B. S. Roden, Kenneth W. Kinzler, Nickolas Papadopoulos, Bert Vogelstein, Luis A. Diaz, Charles N. Landen. . (2014) Detection of Somatic TP53 Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer. Obstetrics & Gynecology 124:5, 881-885.
CrossRef 278 Jean-François Bretagne. . (2014) Dépistage du cancer colorectal : il faut évoluer. La Presse Médicale 43:11, 1165-1167. CrossRef 279 Fabrizio Stracci, Manuel Zorzi, Grazia Grazzini. . (2014) Colorectal Cancer Screening: Tests, Strategies, and Perspectives. Frontiers in Public Health 2. CrossRef 280 R. J. C. Steele. . (2014) Colorectal cancer screening. British Journal of Surgery 101:11, 1338-1340.
CrossRef 281 Irfan A. Qureshi, Mark F. Mehler. . (2014) Epigenetic Mechanisms Underlying the Pathogenesis of Neurogenetic Diseases. Neurotherapeutics 11:4, 708-720. CrossRef 282 Jiangjiang Zhu, Danijel Djukovic, Lingli Deng, Haiwei Gu, Farhan Himmati, E. Gabriela Chiorean, Daniel Raftery. . (2014) Colorectal Cancer Detection Using Targeted Serum Metabolic Profiling. Journal of Proteome Research 13:9, 4120-4130.
CrossRef 283 James J. Goedert, Joshua N. Sampson, Steven C. Moore, Qian Xiao, Xiaoqin Xiong, Richard B. Hayes, Jiyoung Ahn, Jianxin Shi, Rashmi Sinha. . (2014) Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis 35:9, 2089-2096. CrossRef 284 Joseph C. Anderson, Robert D. Shaw. . (2014) Update on Colon Cancer Screening: Recent Advances and Observations in Colorectal Cancer Screening.
Current Gastroenterology Reports 16:9. CrossRef 285 Yi-Chia Lee. . (2014) How sensitive is fecal immunochemical testing in detecting colorectal neoplasms?. Advances in Digestive Medicine 1:3, 69-71. CrossRef 286 Angela A Guzzetta, Thomas R Pisanic II, Prateek Sharma, Joo Mi Yi, Alejandro Stark, Tza-Huei Wang, Nita Ahuja. . (2014) The promise of methylation on beads for cancer detection and treatment.
Expert Review of Molecular Diagnostics 14:7, 845-852. CrossRef 287 Laura Huth, Jörg Jäkel, Edgar Dahl. . (2014) Molecular Diagnostic Applications in Colorectal Cancer. Microarrays 3:3, 168-179. CrossRef 288 Barcey T Levy, Camden Bay, Yinghui Xu, Jeanette M Daly, George Bergus, Jeffrey Dunkelberg, Carol Moss. . (2014) Test Characteristics of Faecal Immunochemical Tests (FIT) Compared with Optical Colonoscopy.
Journal of Medical Screening 21:3, 133-143. CrossRef 289 Hicham Mansour. . (2014) Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection. Frontiers in Genetics 5. CrossRef 290 Carrie Printz. . (2014) New findings in colon cancer incidence, screening. Cancer 120:15, 2224-2225. CrossRef 291 Arie Knuistingh Neven. . (2014) Screening coloncarcinoom: feces- of DNA-test?.
Huisarts en wetenschap 57:8, 389-389. CrossRef 292 John B. Kisiel, Tracy C. Yab, William R. Taylor, Douglas W. Mahoney, David A. Ahlquist. . (2014) Stool Methylated DNA Markers Decrease Following Colorectal Cancer Resection—Implications for Surveillance. Digestive Diseases and Sciences 59:8, 1764-1767. CrossRef 293 (2014) Multitarget Stool DNA Testing for Colorectal-Cancer Screening. New England Journal of Medicine 371:2, 184-188.
Free Full Text 294 Magdalen R.R. Carroll, Helen E. Seaman, Stephen P. Halloran. . (2014) Tests and investigations for colorectal cancer screening. Clinical Biochemistry 47:10-11, 921-939. CrossRef 295 Hong-Jun Yoon, Georgia Tourassi. . (2014) Analysis of online social networks to understand information sharing behaviors through social cognitive theory. Proceedings of the 2014 Biomedical Sciences and Engineering Conference, 1-4.
CrossRef 296 Robertson , Douglas J. , Dominitz , Jason A. , . . (2014) Stool DNA and Colorectal-Cancer Screening. New England Journal of Medicine 370:14, 1350-1351.Full Text 297 Timothy Church. . (2014) Colorectal cancer screening: will non-invasive procedures triumph?. Genome Medicine 6:6, 43. CrossRef
Fast typing with your personal computer can be a quite handy capacity that will are available in handy afterward during your profession. It is actually not having said that a simple means to realize most laptop computer consumers typing at mediocre speeds and even right after a very long time of possessing these kinds of a device they continue to have remained within the exact same typing velocity that they had every time they to start with purchased the machine.See Also: Typing Challenge Words Per Minute
Not a soul can stay away from making use of the pc because the personal computer has actually been a device currently. Substantially as people may pride by themselves on their excellent typing, but sad to say not all of these are born typists. In addition they have expert the prolonged typing method from becoming typing novices to qualified typists likewise. Of course, it is a wise option to pick out a very good typing tutor after they begin to learn to style. Especially for you, to be a rookie, decide on a superb typing tutor is meaning to choose an excellent teacher.
With DNA Testing, Suddenly They Are FamilyBy RACHEL L. SWARNSJanuary 23, 2012ST. LOUIS — Growing up, Khrys Vaughan always believed that she had inherited her looks and mannerisms from her father, and that her appreciation for tradition and old-fashioned gentility stemmed from her parents’ Southern roots. But those facets of her self-image crumbled when she was told, at age 42, that she had been adopted.
She began searching for her origins, only to find out that her adoption records had been sealed, a common practice in the 1960s. Then Mrs. Vaughan stumbled across an ad from a DNA testing company offering to help people who had been adopted find clues to their ancestry and connections to blood relatives. About five weeks after shipping off two tiny vials of her cells from a swab of her cheek, Mrs.
Vaughan received an e-mail informing her that her bloodlines extended to France, Romania and West Africa. She was also given the names and e-mail addresses of a dozen distant cousins. This month, she drove 208 miles from her hometown here to Evansville, Ind., to meet her third cousin, the first relative to respond to her e-mails. Mrs. Vaughan is black and her cousin is white, and they have yet to find their common ancestor.
But Mrs. Vaughan says that does not matter. “Somebody is related to me in this world,” she said. “Somebody out there has my blood. I can look at her and say, ‘This is my family.’ ”A growing number of adoptees, now in the thousands, are turning to DNA testing companies in hopes of piecing together the puzzles of their beginnings. Some long to learn whether their family trees first bloomed in Ireland or Italy, Europe or South America.
Others want to know whether they are genetically predisposed to developing diabetes, cancer or other diseases. Most adoptees are hungry for information that will lead to their birth parents, but some are also expanding their conception of family as they embrace a far-flung constellation of second, third and fourth cousins. Some DNA testing companies have been stepping up their efforts to reach out to this community over the past several years, posting advertisements on adoption message boards and testimonials on their Web sites.
Adoptees and some groups that serve them are also spreading the word. “There has never been a better time to establish your biological identity,” says the Web site of Adoption.com, which promotes its efforts to unite adoptees and blood relatives. Genetic testing has surged in popularity over the last decade, as the cost of analyzing cell samples has dropped and as Americans have grown more interested in learning about their heritage.
As a result, some companies have amassed enough DNA samples that they can offer to help adoptees identify their kin, bringing hope to people born in an era when adoption records were routinely sealed, leaving few paper trails to follow. Several companies provide tests that can confirm whether adoptees are related to individuals they already know. Others cast a wider net by plugging DNA results into databases that contain tens of thousands of genetic samples, provided mostly by people searching for their ancestral roots.
The tests detect genetic markers that reveal whether people share a common ancestor or relative.Some experts on adoption and genetics have criticized ancestry and genealogy testing companies, saying they are, at times, connecting people whose genetic links are tenuous — in effect stretching the definition of a relative. Nevertheless, the growing popularity of the tests, combined with social media sites that connect people day to day, has given some adoptees a sense of family that feels tangible, intimate and immediate.
Within minutes of receiving the names of her distant relatives, Mrs. Vaughan, a freelance project manager, was admiring their photographs on Facebook. Another adoptee who found family through DNA testing, Kathy Borgmann, a 49-year-old corn farmer in New Palestine, Ind., exchanged e-mails with cousins who delighted her by saying, “Welcome to the family.” Alan Bogner of Olympia, Wash., felt such kinship with his newly discovered second and third cousins that he attended their family reunion in Iowa.
He learned, among other things, that many of them were also tall — he is 6-foot-5 — and that they shared his liberal politics. “It sounds so baloney, but they’re just so much like me,” said Mr. Bogner, 54, who works for the governor’s office. The tests have their limitations. The price of testing can range from $99 to more than $500, putting them out of reach for some people. Company officials also caution that it is much more common to find second and third cousins than birth parents or siblings.
Neil Schwartzman of Montreal struck gold when his test connected him with his sister — “I was gob-smacked,” he recalled — but such cases are not typical. Company officials say the odds are improving, though, as more people pay for tests and add their DNA to the pool of potential matches. Two testing companies — Family Tree DNA and 23andMe — have databases that contain samples from 350,000 and 125,000 people, respectively, and their executives say those numbers are rising.
In recent years, about 9,000 of their customers have identified themselves as adoptees, company officials say, but they believe the actual number is larger since not everyone shares their reasons for testing.For somebody looking for a match, “maybe there’s no one in the database today, but in two years a first cousin might be there,” said Anne Wojcicki, the chief executive of 23andMe. DNA testing companies, which compete for customers, do not pool their databases, so people often submit samples to more than one.
Not everyone is hoping to find new relatives. Some adoptees who have found genetic matches have been rebuffed by their distant kin. Most people take genealogical DNA tests to fill gaps in their family trees, not to find new members of their clans. Mr. Bogner said several cousins identified through DNA testing stopped communicating once they learned he was adopted. “It was horribly disappointing,” he said.
Elizabeth Bartholet, an expert on adoption at Harvard Law School, said the proliferation of testing highlights the need for broader access to adoption records. In the meantime, she says, adoptees would be better served by nurturing the relationships they already have. But Mrs. Vaughan, who is now 44, said her newfound relatives have filled a void in her life. Her adoptive father died when she was 9, and she had found comfort over the years knowing that she shared his smile.
“I was crying because I wasn’t Daddy’s little girl,” said Mrs. Vaughan, describing the day that her adoptive mother finally told her the truth. “I needed to find my place in the world.”She sent out her first e-mail to a cousin identified by Family Tree DNA in March. It landed in the inbox of Jennifer Grigsby, a research analyst from Somerset, Ky., who read it with astonishment. Mrs. Grigsby had taken a DNA test to learn more about her lineage.
“I wasn’t looking for a new relationship,” she said. But when the two women started talking, “there was like an instant connection,” said Mrs. Grigsby, 37. They started exchanging e-mails and Facebook messages every week, and calling once or twice a month. A few weeks ago, they decided to meet in Evansville, midway between their homes. But three days before their get-together, Mrs. Vaughan learned the identity of her birth mother.
The courts had determined that her mother had died in 2005, which meant that her name could finally be released. The discovery led her to four sisters.Mrs. Grigsby offered to cancel their plans so Mrs. Vaughan could connect with her siblings. But Mrs. Vaughan would have nothing of it. Last week, she drove more than three hours to see the first blood relative who had embraced her as family. “Finally!” she said when they met, and she hugged her third cousin as if she would never let go.
We're interested in your feedback on this page. Tell us what you think.
Title: Dna Testing St Louis